Literature DB >> 9001189

Localization and clinical significance of thyrotropin receptor mRNA expression in orbital fat and eye muscle tissues from patients with thyroid-associated ophthalmopathy.

Y Hiromatsu1, M Sato, Y Inoue, M Koga, I Miyake, J Kameo, S Tokisawa, D Yang, K Nonaka.   

Abstract

We have studied the cellular localization of thyrotropin receptor (TSH-R) mRNA in orbital fat and extraocular muscle tissues from patients with thyroid-associated ophthalmopathy (TAO) using Northern blot, reverse transcriptase polymerase chain reaction (RT-PCR), and in situ hybridization, and we correlated the findings with clinical estimates of ophthalmopathy. Although we failed to detect TSH-R mRNA in orbital tissues by Northern blot, TSH-R cDNA was amplified in orbital fat tissue from 13 of 25 patients with TAO and from 2 of 4 control subjects, in eye muscle tissue from 2 out of 7 patients with TAO, and in cultured orbital fibroblasts and subcutaneous fibroblasts from TAO patients. In situ hybridization showed that TSH-R mRNA was detected in cultured orbital fibroblasts as well as skin fibroblasts obtained from the patient. Furthermore, the expression of TSH-R mRNA in orbital fat tissue from patients with TAO significantly correlated with the orbital fat volume and the severity of ophthalmopathy, especially the extent of eye muscle dysfunction. These results suggest that the expression of TSH-R in the orbit, especially fibroblasts, may play a role in the pathogenesis and clinical manifestations of the ophthalmopathy in patients with TAO, although a secondary effect, involving fibroblasts in TAO is also possible.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9001189     DOI: 10.1089/thy.1996.6.553

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  9 in total

Review 1.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

2.  Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis.

Authors:  Seema Kumar; Alexey Leontovich; Michael J Coenen; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

3.  Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization.

Authors:  S L Wu; C S Yang; H J Wang; C L Liao; T J Chang; T C Chang
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 4.  Pathogenesis of ophthalmopathy in autoimmune thyroid disease.

Authors:  A E Heufelder
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

5.  Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.

Authors:  Seema Kumar; Michael J Coenen; Philipp E Scherer; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

Review 6.  [Endocrine orbitopathy 1998].

Authors:  G Förster; G Kahaly
Journal:  Med Klin (Munich)       Date:  1998-06-15

7.  Eye findings and immunological markers in probands and their euthyroid relatives from a single family with multiple cases of thyroid autoimmunity.

Authors:  Melissa Ardley; Thomas McCorquodale; Hooshang Lahooti; Bernard Champion; Jack R Wall
Journal:  Thyroid Res       Date:  2012-06-28

8.  Determinants of extraocular muscle volume in patients with graves' disease.

Authors:  Samer El-Kaissi; Jack R Wall
Journal:  J Thyroid Res       Date:  2012-02-15

9.  Clinical efficacy of transcutaneous triamcinolone acetonide injection for upper eyelid retraction and swelling in patients with thyroid eye disease.

Authors:  Ai Kozaki; Hiroshi Nakamura; Toshu Inoue
Journal:  Int Med Case Rep J       Date:  2018-11-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.